Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial

BACKGROUND: Vernal keratoconjunctivitis (VKC) is a bilateral, recurrent, chronic conjunctival inflammatory disease with seasonal exacerbations. This study aimed to assess the efficacy and safety of tacrolimus 0.03% eye ointment in the management of chronic VKC. METHODS: This was an open-label, prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltagoury, Mahmoud, Abou Samra, Waleed, Ghoneim, Ehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Virtual Ophthalmic Research Center 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445306/
https://www.ncbi.nlm.nih.gov/pubmed/37641784
http://dx.doi.org/10.51329/mehdiophthal1446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445306/
https://www.ncbi.nlm.nih.gov/pubmed/37641784
http://dx.doi.org/10.51329/mehdiophthal1446

Ejemplares similares